Abstract
SummaryLymphocytes recovered from normal donors and from patients with CLL were examined for interferon-producing capacity, following treatment with tilorone hydrochloride in vitro. The interferon response observed in normal lymphocyte cultures appeared to be correlated with the toxic effect of the inducer. The effect observed in the leukemic lymphocyte cultures was delayed, but of a similar magnitude. The data indicate that leukemic cells are either more resistant to the toxic effects of this agent, or their metabolic activity is less than observed in normal lymphocytes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
